Latest Breaking News On - Society for inherited metabolic disorders - Page 5 : comparemela.com

Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting

17.03.2023 - Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting 17-March-2023 . Seite 1

Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting

Jnana Therapeutics to Present Preclinical Data on its PKU Program at the 2023 Society for Inherited

Phase 1a clinical trial of JNT-517 in healthy volunteers approaching completionBOSTON (BUSINESS WIRE) Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, will present preclinical data for its lead.

Cyclo Therapeutics (CYTH) Provides Clinical Program Update and Highlights Recent Achievements

Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting